02/14/2025
4:18 PM | ARMISTICE CAPITAL, LLC (Filed by)
Rigel Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025
12:42 PM | Invesco Ltd. (Filed by)
Rigel Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/06/2025
7:26 PM | Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
7:27 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
7:27 PM | Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
7:27 PM | Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
2:40 PM | Rigel Pharmaceuticals (Subject)
RODRIGUEZ RAUL R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2025
2:41 PM | Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2025
2:43 PM | Rigel Pharmaceuticals (Subject)
Schorno Dean L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2025
2:58 PM | Rigel Pharmaceuticals (Subject)
Santos David A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
Rigel Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
Get the Latest News and Ratings for RIGL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Rigel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/04/2025
3:39 PM | Rigel Pharmaceuticals (Subject)
Schorno Dean L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/04/2025
3:30 PM | Rigel Pharmaceuticals (Subject)
RODRIGUEZ RAUL R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/04/2025
3:20 PM | Rigel Pharmaceuticals (Subject)
Santos David A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/04/2025
3:21 PM | Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
5:47 PM | Rigel Pharmaceuticals (Issuer)
Rojkjaer Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
5:45 PM | Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
5:47 PM | Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
5:47 PM | Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
5:47 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
7:49 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:38 PM | Masuda Esteban (Reporting)
Rigel Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
7:15 AM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
7:01 PM | Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
7:01 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
7:01 PM | Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
8:33 AM | Invesco Ltd. (Filed by)
Rigel Pharmaceuticals (Subject)
| Form SC 13G | |
11/07/2024
3:22 PM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:01 PM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2024
7:36 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:33 PM | Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
7:30 AM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2024
11:15 PM | Rigel Pharmaceuticals (Filer)
| Form EFFECT | |
06/27/2024
3:31 PM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
7:45 AM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
6:19 PM | Ali-Jackson Kamil (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
6:20 PM | HANNAH ALISON L. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
6:20 PM | Kotzin Brian L. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
6:20 PM | LAPOINTE ANTHONY GREGG (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
6:21 PM | MOOS WALTER H (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
6:21 PM | Rigel Pharmaceuticals (Issuer)
Wasman Jane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad) If you missed out on the big boom in Nvidia…
Listen up, because according to Nvidia's own CEO…
Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry. You MUST act before March 17th. |
05/29/2024
3:06 PM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:05 PM | Rigel Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/12/2024
7:05 AM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
4:29 PM | Rigel Pharmaceuticals (Filer)
| Form ARS | |
04/10/2024
3:49 PM | Rigel Pharmaceuticals (Filer)
| Form DEF 14A | |
04/10/2024
3:50 PM | Rigel Pharmaceuticals (Filer)
| Form DEFA14A | |
03/29/2024
4:04 PM | Rigel Pharmaceuticals (Filer)
| Form PRE 14A | |
03/29/2024
3:09 PM | Rigel Pharmaceuticals (Issuer)
Rojkjaer Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:14 PM | Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:15 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:15 PM | Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:16 PM | Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:00 AM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
